Recipharm- Advanced Bio
Recipharm- Advanced Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs). Recipharm- Advanced Bio’s specialized CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. Headed by a management team and technical experts with a proven track record in both process development and contract manufacturing, Recipharm- Advanced Bio offers the knowledge and resources necessary to help customers develop and manufacture promising new therapies to meet the needs of patients across the world.
